Failing Is An Option, Giving Up Is Not

Failing Is An Option, Giving Up Is Not

Failing is just the "First Attempt In Learning"
91
views

All right, yall. I'm here to give you your weekly dose of #vulnerability. I'm really good at being sarcastic, I'm really bad at expressing emotions. So here we are.

For those of you who don't know (i.e probably EVERYONE WHO CLICKED ON THIS ARTICLE), I have bipolar II, and before I was diagnosed BP II, I had gone through 7 different diagnoses. Lo and behold, they found something that included ALL my symptoms, so here I am in my little bipolar state of life. The bad thing about being bipolar is that I'm bipolar, the GOOD thing about being bipolar is that you can usually get your mental health straightened out pretty well with therapy and meds. Unfortunately for me, I'm a broke college student with parents who don't believe in medication, so here I am in my little bubble (don't worry y'all, I got it all figured out. Got me a savings account and EVERYTHING).

Regardless of what my diagnosis is, and regardless of what yours is, I'm here to tell you that failure is A-Ok, and it's a totally viable option. The option that isn't okay-- giving up. I feel like we're told all throughout life that failure isn't an option, and up until my sophomore year of high school, I believed this. But then I saw a sign on the wall in my high school (side note: I went to a high school with literally less than 250 students, and mental health issues ran rampant, so most people were pretty understanding) that said "FAIL: First Attempt In Learning".

Let me tell you, that hit me like a motherf*cking wall. Failing IS the first attempt in learning. Like when you starting walking you probably fell down around 9 million times before you figured it out.

Back to why my mental health and failing is totally viable. So, on a personal note, this past semester has been extremely difficult for me. The depression hit hard. And so, I've decided to drop one of my classes, take an incomplete in the other two, and work my ass off in the last one. While my GPA might be low, while taking an incomplete might be "failing", to me this isn't giving up.

I needed to start over after some time of getting my meds situated, after getting back up again, after re-starting therapy, after finding my footing. So while I'm failing, I'm not giving up (even though sometimes I REALLY REALLY WANT TO).

So, what is your takeaway from all this, be you mentally ill or not? Fail. Fail all the time to learn if you need to. Failing is the first attempt in learning, failing is the first attempt in life. But fail responsibly. Learn from your mistakes, and move on. Failing is an option, giving up is not.

Cover Image Credit: Pixabay

Popular Right Now

Needle Free Drug Delivery Devices Market Opportunity will Rise to US$13 bn by 2023

Transparency Market Research Report Added "Needle Free Drug Delivery Devices Market" to its database.
2
views

 

The global needle free drug delivery devices market is anticipated to grow significantly over forecast period from 2015 to 2023. This growth is credited mainly to increasing urgency for preventive steps for needle-stick injuries. The needle-free drug delivery market contains several vendors. To present new products and upgrade existing ones to achieve more advanced, creative, and easy to use item, organizations are intensely investing into research and development. Numerous organizations are intensely investing into shares as well of microneedle drug delivery frameworks to acquire more and more market shares. The launch of new devices and technologies will intensify the market's competitive scenario. Antares Pharma Inc., Injex Pharma AG, Zogenix Inc., Glide Pharmaceutical Technologies Ltd., Pharmajet Inc., and 3M are among the key players dominating the global needle free drug delivery devices market.  

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=447 

According to Transparency Market Research, the global market for needle-free drug delivery devices is expected to account a noteworthy rise within the span of few upcoming years because of the growing demand for effortless delivery of solutions over the world. Experts gauge this market to keep on flourishing consistently at a solid CAGR of 9.90% within the duration of 2015 to 2023 and increase its evaluation from worth US$5.4 bn in year to US$13 bn by 2023. Based on geography, the North America region was analyzed to dominate the other region in 2014. Owing to rise in number of patients in North America and rising geriatric population in Europe region have propelled these regions to lead the global market. The insulin delivery segment registered the major usage among other segments in 2014, and is expected to continue in coming years as well.  

Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=447 

Prevalence of Self-Administration of Drugs to Propel Global Market 

The growing inclination towards the self-administration of several drugs is one of the major propelling reason that is driving the market growth, within the forecast period. There are huge number of patient who are preferring self-administration of medicines with the help of needle free drug delivery device. The main reason behind this is the reduction in the healthcare expenses. It is worth noting that the launch of self-injectable drugs in rheumatoid arthritis encouraged people to go for self-administered drugs. There has been a significant rise in patient using self-administered drugs, since past few years. This has highly supported the overall market growth of needle free drug delivery device, as they reduce the risk of injuries due to needle-stick, coupled with cross contamination. Moreover, owing to the treatment in non-medical surrounding, it also lessens the overall medical expenses.  

Rise in Chronic Illness Encourages Use of Needle Free Drug Delivery Devices 

The rising prevalence of chronic disorders, for example, hepatitis, dengue, and AIDS, and diverse cardiovascular and neurological contaminations, which require endless administration of drugs, is as well foreseen to contribute in the increasing demand for needle free drug delivery devices market. Needle free drug delivery devices are mostly used in case of injecting insulin in the human body. The insulin delivery segment has been driving the application segment since the past few years and is foreseen to remain dominant over the coming years.  

Read Report Overview: https://www.transparencymarketresearch.com/needle-free-delivery-devices-market.html 

The growing cases of neurological and cardiovascular diseases, the infrastructural progression in the healthcare and service industry, and the rise in investments of driving players around in the regions because of ignored healthcare needs in the past are foreseen to help the demand for needle free drug delivery devices in Asia Pacific region very soon. These devices are furthermore anticipated that would experience a significant surge in Latin America and the Middle East and Africa as a result of the betterment in healthcare services in these regions in past few years.  

Key Takeaways:  


  • The growing inclination towards the self-administration of several drugs is one of the major propelling reason that is driving the market growth, within the forecast period.  
     
  • Owing to the treatment in non-medical surrounding, it also lessens the overall medical expenses.  
     

Request For Discount On This Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=447 

About us:  

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.  

Contact us:  

Transparency Market Research  

90 State Street,  

Suite 700,  

Albany  

NY - 12207  

United States  

Tel: +1-518-618-1030  

USA - Canada Toll Free 866-552-3453  

Email: sales@transparencymarketresearch.com 

Website: http://www.transparencymarketresearch.com/

 

Related Content

Connect with a generation
of new voices.

We are students, thinkers, influencers, and communities sharing our ideas with the world. Join our platform to create and discover content that actually matters to you.

Learn more Start Creating

2018 Global and Europe Insulin Glargine Market analysis and Industry Forecast

The Report Insulin Glargine provides information about product categories and a customized business model.
1
views

Global Insulin Glargine Market Research report peaks the key concerns of the Insulin Glargine market including highest sectors tangled, product classification, product price, growth rate, current synopsis of the Insulin Glargine industry along with product upgradation and innovations. Worldwide Insulin Glargine market is predominantly classified on the basis of leading marketing players, product types, applications and worldwide regions covering North America, South America, Africa and Middle East, Europe and Asia-Pacific. Global Insulin Glargine Market volume is expected to spectacle development of xx% CAGR and growth of $$ million USD within next five years.

Request Sample Copy of Insulin Glargine Market Research Report Here : https://www.marketresearchexplore.com/report/global-and-europe-insulin-glargine-market-status-and-future-forecast-2013-2023/68948

Global Insulin Glargine Market Research report additionlly delivers competitive scenario of the Insulin Glargine market that gathers information concerning the company profiles, their contact knowledge, market share, company’s headquarters and corporate office, and sales revenue. The report also involve different plans and policies of the Insulin Glargine industry, the process of manufacturing the product, product images, Insulin Glargine product draft, and production volume. Additionally, Insulin Glargine market gives a tenor of market utilization value, investment return analysis, investment feasibleness, product volume, market strategies, industry chain structure, supply and demand ratio and market chain value. Conclusively, the Insulin Glargine Market Research report inspects distinct traders, distributors and suppliers of Insulin Glargine industry along with sales channel, data resources, research findings and appendix.

Company Coverage :-

Sanofi-Aventis
Ganlee
Biocon

Application Coverage: –

Treat type 1 diabetes
Treat type 2 diabetes

Product Type Coverage :-

Single Dose Vial
Pre-filled Syringe

Inquiry Before Buying Click Here : https://www.marketresearchexplore.com/report/global-and-europe-insulin-glargine-market-status-and-future-forecast-2013-2023/68948#enquiry

Fundamental specks included in Global Insulin Glargine Market Research report are as follows:

The first section of the Insulin Glargine Market Research report focal points industry overview, upstream and downstream market segmentation and the cost analysis. The second and third section gives a convenient idea of the industry environment, Insulin Glargine market by type along with segment overview, market forecast and market size.

Next two sections that is fourth and fifth list down the top manufacturers and companies involved in the Insulin Glargine market and competitive scenarios of these market players. The sixth section includes Insulin Glargine market demand, demand situation, demand comparison according to geographical regions and demand forecast.

Seventh and eighth section highlights regional operation, by regions with forecast, product margin, cost of the product, value chain and sales channel. The last section of the Insulin Glargine Market report demonstrates research findings and conclusion.

Related Content

Facebook Comments